Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria

Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

JAMA Ophthalmol.

Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group

doi: 10.1001/jamaophthalmol.

RECOMMENDED

Retinal Diseases

Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study

JAMA Ophthalmol.

Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group

doi: 10.1001/jamaophthalmol.

Validation of the Colorado Retinopathy of Prematurity Screening Model

JAMA Ophthalmol.

McCourt EA, Ying GS, Lynch AM, Palestine AG, Wagner BD, Wymore E, Tomlinson LA, Binenbaum G

doi: 10.1001/jamaophthalmol.

Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model

JAMA Ophthalmol.

Binenbaum G, Ying GS, Tomlinson LA; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Acta Ophthalmol.

van der Heijden AA, Abramoff MD, Verbraak F, van Hecke MV, Liem A, Nijpels G

doi: 10.1111/aos.13613.

Retinal DiseasesFurther Publications

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)

Prog Retin Eye Res

Tsai AS, Chou HD, Ling XC, Al-Khaled T, Valikodath N, Cole E, Yap VL, Chiang MF, Chan RVP, Wu WC

doi: 10.1016/j.preteyeres.2021.101018

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

Ophthalmology.

VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR

doi: 10.1016/

Blindness and Vision ImpairmentRetinal DiseasesFurther Publications

The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China

BMC Ophthalmol

Guo Z, Ma N, Wu Y, Yuan H, Luo W, Zeng L, Jie H, Li S

doi: 10.1186/s12886-021-02018-x

Retinal Diseases

Interventions to increase attendance for diabetic retinopathy screening

Cochrane Database Syst Rev.

Lawrenson JG, Graham-Rowe E, Lorencatto F, Burr J, Bunce C, Francis JJ, Aluko P, Rice S, Vale L, Peto T, Presseau J, Ivers N, Grimshaw JM

Related content

Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study

Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study

Validation of the Colorado Retinopathy of Prematurity Screening Model

Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology

The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China

Interventions to increase attendance for diabetic retinopathy screening